Fortis Healthcare Limited FORTIS
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on FORTIS
Real prices, every charge counted. Pick one or write your own.Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 13 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Are its options cheap or dear?It compares the movement option prices assume with the movement the share has actually shown.
Live in market hoursImplied volatility needs the live option chain, which is open 9:15 to 3:30.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Against its sectorWhere this company ranks among similar companies on each measure.
Hospital · 28 peers · mediansWhat the numbers sayShort plain statements about this company's latest figures.
Written by fixed rulesLatest quarterIn the quarter to September 2026 (results filed 5 Nov 2026), sales rose 17.3% from a year earlier to ₹2,735 cr and profit fell 2.5% to ₹320 cr.
- Sales grew 4 years running (₹5,718 cr in FY22 to ₹9,128 cr in FY26).
- Profit grew 3 years running (₹633 cr in FY23 to ₹1,064 cr in FY26).
- Operating margin rose from 17.5% in FY23 to 22.8% in FY26.
- Cash from operations was at least the reported profit in each of FY24, FY25, FY26.
- Foreign institutions cut their holding by 4.0 points over 5 quarters (27.17% to 23.19%).
- Domestic institutions raised their holding by 4.7 points over 5 quarters (29.79% to 34.46%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
How the share moved on resultsWhat the share price did around each recent quarterly result.
Over the last 20 results, the share rose on 6 and fell on 14, and moved by 3% or more on 7.
Q2 FY27: results filed 5 Nov 2026. The share went from its close on 4 Nov 2026 to its close on 6 Nov 2026 -3.00%.
Dividends paidCash the company has paid per share, year by year.
2026 has paid ₹1.00 per share, about ₹131 on ₹1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividendsHeld for 15 years this compounded at +12.6% a year. The last twelve months were down -19.8%. Price only, before dividends.
Who owns itThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Shareholding patternEach line is that holder's share of all shares over the last 6 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsAt a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Hospital. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
The business, year by yearSales and net profit by financial year or by quarter.
Sales and net profitWhere every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.
FY26In FY26, of every ₹100 of sales it kept ₹11.7 as profit. Other income added ₹0.6.
How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.
Compounded a yearWhere the cash wentProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
From the cash flow statementIn FY26 cash rose by ₹228 Cr, after ₹946 Cr spent on plant and equipment.
Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales in this financial year against the previous one. | 10.1% | 9.5% | 12.9% | 17.3% |
| Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax. | 17.5% | 18.4% | 20.4% | 22.8% |
| Net marginOf every ₹100 of sales in the year, how much was left as profit after everything. | 10.1% | 9.4% | 10.4% | 11.7% |
| ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | 7.8% | 7.8% | 9.1% | 11.0% |
| ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders. | 10.2% | 10.6% | 11.2% | 13.5% |
| Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | 0.11x | 0.10x | 0.27x | 0.28x |
| Interest coverHow many times the company's profit before interest could pay its interest bill. | 7.1x | 7.5x | 6.4x | 5.3x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Hospital| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP Apollo Hospitals Enterprise Limited | 1.23 L cr | 54.7x | 11.6x | 21.5% | 20.7% | 0.50 | 8.4% | +20.8% | 0.23% |
| MAXHEALTH Max Healthcare Institute Limited | 92,182 cr | 66.7x | 8.1x | 14.3% | 14.4% | 0.33 | 15.1% | +20.3% | 0.21% |
| MANIPALHOS Manipal Health Enterprises Limited | 89,630 cr | - | 5.4x | - | - | 0.34 | - | - | 0.00% |
| ASTERDM Aster DM Quality Care Limited | 62,978 cr | 99.8x | 8.1x | 10.1% | 14.8% | 0.43 | 8.7% | +136.3% | 0.42% |
| FORTIS Fortis Healthcare Limited | 57,679 cr | 55.5x | 5.5x | 11.0% | 13.5% | 0.29 | 10.7% | +17.3% | 0.13% |
| MEDANTA Global Health Limited | 39,094 cr | 63.2x | 9.0x | 15.0% | 17.9% | 0.16 | 12.1% | +33.6% | 0.03% |
| NH Narayana Hrudayalaya Ltd. | 38,019 cr | 44.0x | 7.6x | 19.7% | 16.0% | 0.99 | 8.4% | +73.0% | 0.24% |
| KIMS Krishna Institute of Medical Sciences Limited | 30,646 cr | 139.8x | 7.8x | 9.7% | 9.9% | 0.83 | 4.3% | +39.9% | 0.00% |
| AGARWALEYE Dr. Agarwal's Health Care Limited | 17,462 cr | 102.0x | 7.8x | 8.3% | 15.2% | 0.09 | 8.7% | +31.4% | 0.00% |
| RAINBOW Rainbow Childrens Medicare Limited | 12,914 cr | 44.1x | 7.5x | 17.9% | 27.8% | 0.00 | 15.5% | +23.2% | 0.28% |
| PARKHOSPS Park Medi World Limited | 11,039 cr | 39.7x | 5.1x | 13.0% | 17.7% | 0.20 | 14.7% | - | 0.00% |
| YATHARTH Yatharth Hospital & Trauma Care Services Limited | 10,222 cr | 53.7x | 5.5x | 9.9% | 12.4% | 0.24 | 12.2% | +54.4% | 0.05% |
| JLHL Jupiter Life Line Hospitals Limited | 9,337 cr | 49.9x | 5.7x | 13.7% | 16.0% | 0.36 | 11.4% | +16.0% | 0.07% |
| HCG Healthcare Global Enterprises Limited | 8,554 cr | 807.0x | 6.3x | 1.9% | 9.4% | 0.52 | 0.8% | +13.1% | 0.00% |
| ARTEMISMED Artemis Medicare Services Limited | 5,094 cr | 44.4x | 5.2x | 11.6% | 14.8% | 0.24 | 10.0% | +13.2% | 0.14% |
| INDRAMEDCO Indraprastha Medical Corporation Limited | 3,027 cr | 15.8x | 3.7x | 27.5% | 37.7% | 0.00 | 12.3% | +8.3% | 1.21% |
| DRAGARWQ Dr Agarwals Eye Hospital Limited | 2,942 cr | 38.6x | - | - | - | - | 15.3% | +22.3% | 0.07% |
| KMCSHIL K M C Speciality Hospitals (India) Limited | 2,738 cr | 44.8x | - | - | - | - | 17.5% | +24.1% | 0.00% |
| SHALBY Shalby Limited | 1,340 cr | 35.0x | 1.3x | 3.5% | 6.7% | 0.53 | 3.2% | +9.7% | 0.00% |
| GKSL Gujarat Kidney And Super Speciality Limited | 1,228 cr | 57.0x | 4.7x | 6.6% | 8.6% | 0.06 | 16.2% | +194.6% | 0.00% |
| GPTHEALTH GPT Healthcare Limited | 1,180 cr | 22.6x | 4.1x | 16.3% | 23.1% | 0.05 | 10.2% | +14.1% | 1.39% |
| UNIHEALTH Unihealth Hospitals Limited | 851 cr | - | 8.2x | - | 16.2% | 0.13 | - | - | 0.00% |
| MOMSBELIEF Rays of Belief Limited | 592 cr | - | 3.9x | - | - | 0.15 | - | - | 0.00% |
| LOTUSEYE Lotus Eye Hospital and Institute Limited | 214 cr | 448.0x | 3.5x | 0.1% | 1.2% | 0.29 | 0.8% | +35.9% | 0.00% |
| NEPHROCARE Nephro Care India Limited | 154 cr | - | 2.5x | - | 8.7% | 0.00 | - | - | 0.00% |
| SANGANI Sangani Hospitals Limited | 83 cr | 27.6x | 2.0x | - | 19.6% | 0.04 | 7.6% | +673.8% | 0.00% |
| MAITREYA Maitreya Medicare Limited | 79 cr | - | 2.8x | - | -2.2% | 0.85 | -7.5% | -0.1% | 0.00% |
| AATMAJ Aatmaj Healthcare Limited | 60 cr | 105.6x | 1.2x | - | 3.6% | 0.45 | 1.9% | +56.9% | 0.00% |
| ABH ABH Healthcare Limited | 45 cr | - | 0.9x | - | - | 0.80 | - | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Month by monthThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Price return each month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.7 | +10.7 | -15.7 | +16.1 | +0.6 | +3.1 | -1.3 | -4.0 | -15.1 | -0.2 | -0.5 | · | -13.6% 11m |
| 2025 | -11.1 | -4.3 | +14.0 | -1.8 | +3.0 | +12.5 | +7.9 | +6.3 | +6.4 | +5.5 | -10.2 | -3.8 | +22.8% |
| 2024 | +3.0 | -5.5 | +3.0 | +4.4 | +8.3 | +0.1 | +5.6 | +9.9 | +11.5 | +1.6 | +5.5 | +9.2 | +71.7% |
| 2023 | -1.6 | -5.1 | -2.8 | +0.3 | +5.3 | +14.7 | +9.8 | -4.1 | +2.5 | -5.0 | +19.5 | +8.6 | +46.5% |
| 2022 | -9.1 | -9.2 | +18.3 | -8.0 | -10.9 | +0.8 | +16.0 | +5.7 | -10.2 | +5.0 | +4.6 | -1.4 | -3.8% |
| 2021 | +4.1 | -2.0 | +25.8 | +5.8 | +8.0 | +6.9 | +3.0 | +15.9 | -9.3 | -7.3 | +14.9 | +5.9 | +91.6% |
| 2020 | +16.3 | +0.4 | -18.1 | +0.7 | -8.9 | +5.5 | +13.2 | -3.8 | +1.9 | -7.2 | +20.1 | +2.9 | +17.6% |
| 2019 | -3.8 | -0.3 | +0.7 | +2.1 | -9.6 | +3.8 | -7.8 | +3.5 | +8.9 | +8.6 | -5.5 | -4.9 | -6.1% |
| 2018 | -13.3 | +14.9 | -22.8 | +23.6 | -3.4 | -8.4 | +3.6 | +5.0 | -8.0 | +4.0 | +5.2 | -4.9 | -12.4% |
| 2017 | +1.6 | +4.9 | -6.3 | +21.9 | -11.4 | -17.0 | -4.0 | -6.1 | -1.4 | -0.1 | +0.7 | +10.8 | -11.3% |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2025-11-24 | BNP PARIBAS FINANCIAL MARKETS · bulk | SELL | 1,19,38,263 | ₹921.85 | ₹1,100.53 Cr |
| 2025-11-24 | INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD. · bulk | SELL | 52,81,102 | ₹921.93 | ₹486.88 Cr |
| 2025-10-07 | GOLDMAN SACHS BANK EUROPE SE - ODI · block | BUY | 2,19,013 | ₹1,042.00 | ₹22.82 Cr |
| 2025-10-07 | GOLDMAN SACHS (SINGAPORE) PTE - ODI · block | SELL | 2,19,013 | ₹1,042.00 | ₹22.82 Cr |
| 2025-09-22 | GOLDMAN SACHS (SINGAPORE) PTE · block | BUY | 2,19,013 | ₹953.95 | ₹20.89 Cr |
| 2025-09-22 | AWARE SUPER · block | SELL | 2,19,013 | ₹953.95 | ₹20.89 Cr |
| 2025-09-18 | GOLDMAN SACHS BANK EUROPE SE - ODI · block | BUY | 3,36,879 | ₹963.50 | ₹32.46 Cr |
| 2025-09-18 | GOLDMAN SACHS (SINGAPORE) PTE - ODI · block | SELL | 3,36,879 | ₹963.50 | ₹32.46 Cr |
- Press releasePress Release5 Nov 2026
Fortis Healthcare Limited has informed the Exchange regarding a press release dated November 05, 2026, titled "Fortis Healthcare announces Q2 FY27 Financial Results".
- Board outcomeOutcome of Board Meeting5 Nov 2026
Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
- Press releasePress Release6 Aug 2026
Fortis Healthcare Limited has informed the Exchange regarding a press release dated August 06, 2026, titled "Fortis Healthcare announces Q1 FY27 Financial Results".
- Board outcomeOutcome of Board Meeting6 Aug 2026
Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
- Press releasePress Release22 May 2026
Fortis Healthcare Limited has informed the Exchange regarding a press release dated May 22, 2026, titled "Fortis Healthcare announces Q4 FY26 and FY26 Financial Results".
- Board outcomeOutcome of Board Meeting22 May 2026
Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Press releasePress Release13 Feb 2026
Fortis Healthcare Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Fortis Healthcare announces Q3 FY26 Financial Results".
- Board outcomeOutcome of Board Meeting13 Feb 2026
Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
- Press releasePress Release11 Nov 2025
Fortis Healthcare Limited has informed the Exchange regarding a press release dated November 11, 2025, titled "Fortis Healthcare announces Q2 FY26 Financial Results".
- Integrated Filing- Financial11 Nov 2025
Fortis Healthcare Limited has informed regarding the Un-audited Financial Results for the Quarter and half Year ended September 30, 2025.
- Board outcomeOutcome of Board Meeting11 Nov 2025
Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
- Press releasePress Release6 Aug 2025
Fortis Healthcare Limited has informed the Exchange regarding a press release dated August 06, 2025, titled "press release and earnings presentation for the quarter ended on June 30, 2025.".
- Integrated Filing- Financial6 Aug 2025
Outcome of the Board Meeting for the consideration of Financial Results for June 30, 2025
- Board outcomeOutcome of Board Meeting6 Aug 2025
Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
- Board outcomeOutcome of Board Meeting20 May 2025
Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
- Integrated Filing- Financial7 Feb 2025
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated January 2, 2025, please find attached herewith the Integrated Filing (Financial) for the quarter and nine months ended...
- Financial Result Updates7 Feb 2025
Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test FORTIS. “Buy FORTIS when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free